HIMS

Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

Dollar change +2.66
Percentage change 7.65	%

Peers: CVS WBA TDOC AMZN JNJ UNH HUM CI PFE GDRX

| Held by: VTI IJH VB IWM VXF VBK IWO IJK VTWO SCHA

Index	RUT	P/E	69.95	EPS (ttm)	0.53	Insider Own	18.09%	Shs Outstand	212.46M	Perf Week	7.84%
Market Cap	8.31B	Forward P/E	43.50	EPS next Y	0.86	Insider Trans	-7.44%	Shs Float	181.97M	Perf Month	-24.09%
Income	126.04M	PEG	2.25	EPS next Q	0.11	Inst Own	73.61%	Short Float	28.49%	Perf Quarter	31.03%
Sales	1.48B	P/S	5.63	EPS this Y	12.77%	Inst Trans	19.27%	Short Ratio	2.43	Perf Half Y	121.10%
Book/sh	2.16	P/B	17.33	EPS next Y	43.88%	ROA	21.62%	Short Interest	51.84M	Perf Year	127.00%
Cash/sh	1.35	P/C	27.68	EPS next 5Y	31.05%	ROE	30.71%	52W Range	11.20 - 72.98	Perf YTD	54.71%
Dividend Est.	-	P/FCF	41.91	EPS past 5Y	17.22%	ROI	25.92%	52W High	-48.74%	Beta	1.59
Dividend TTM	-	Quick Ratio	1.50	Sales past 5Y	62.28%	Gross Margin	70.39%	52W Low	234.02%	ATR (14)	4.46
Dividend Ex-Date	-	Current Ratio	1.79	EPS Y/Y TTM	614.50%	Oper. Margin	4.61%	RSI (14)	49.53	Volatility	9.65% 11.99%
Employees	1637	Debt/Eq	0.02	Sales Y/Y TTM	69.33%	Profit Margin	8.54%	Recom	2.47	Target Price	45.88
Option/Short	Yes / Yes	LT Debt/Eq	0.02	EPS Q/Q	1830.36%	Payout	0.00%	Rel Volume	1.23	Prev Close	34.75
Sales Surprise	2.18%	EPS Surprise	1.57%	Sales Q/Q	95.09%	Earnings	Feb 24 AMC	Avg Volume	21.33M	Price	37.41
SMA20	2.01%	SMA50	-3.37%	SMA200	44.46%	Trades		Volume	26,272,670	Change	7.65%

Date	Action	Analyst	Rating Change	Price Target Change
Feb-18-25	Downgrade	Morgan Stanley	Overweight → Equal-Weight	$42 → $60
Jan-10-25	Downgrade	Citigroup	Neutral → Sell	$24 → $25
Jan-07-25	Initiated	BTIG Research	Buy	$35
Dec-17-24	Initiated	Morgan Stanley	Overweight	$42
Nov-14-24	Downgrade	BofA Securities	Buy → Underperform
Aug-22-24	Initiated	Needham	Buy	$24
Aug-09-24	Downgrade	Imperial Capital	Outperform → In-line
May-22-24	Downgrade	Citigroup	Buy → Neutral	$16 → $20
Apr-16-24	Downgrade	Jefferies	Buy → Hold	$17 → $15
Apr-10-24	Initiated	Canaccord Genuity	Buy	$20
Feb-28-24	Upgrade	Imperial Capital	In-line → Outperform	$16
Feb-26-24	Initiated	Leerink Partners	Market Perform	$10
Dec-07-23	Initiated	Imperial Capital	In-line	$9
Jul-28-23	Initiated	TD Cowen	Outperform	$11
Apr-11-23	Initiated	Robert W. Baird	Neutral	$10
Feb-09-23	Upgrade	Jefferies	Hold → Buy	$7 → $11
Nov-08-22	Upgrade	SVB Leerink	Mkt Perform → Outperform	$5
Nov-08-22	Upgrade	BofA Securities	Neutral → Buy	$7.50 → $8.50
Oct-17-22	Downgrade	Piper Sandler	Overweight → Neutral	$8 → $6
Sep-07-22	Initiated	Truist	Hold	$7

Show Previous Ratings

Mar-24-25 12:44PM	Why Novo Nordisk Stock Dropped on Monday, but Eli Lilly and Him & Hers Health Popped (Motley Fool) +7.65%
11:47AM	Illumina's AGD Project Completes 250,000 Whole Genomes: Stock to Gain? (Zacks)
11:37AM	New Thrombectomy Product Launches Support PEN Stock Amid Macro Issues (Zacks)
08:01AM	Hims & Hers Health (HIMS) Moves 5.7% Higher: Will This Strength Last? (Zacks)
Mar-22-25 03:20AM	BUZZ Investing: Fed's Glimmer Of Hope Amid Market Corrections (SeekingAlpha)
03:16AM	Loading…
03:16AM	Why Hims & Hers Health Inc. (HIMS) Went Up On Friday? (InsiderMonkey)
Mar-21-25 08:22AM	GMED Stock Jumps 41.8% in a Year: What's Behind the Rally? (Zacks) +5.72%
Mar-20-25 04:38PM	Hims & Hers Health: Developing A Better Understanding (SeekingAlpha)
01:40PM	Jumping Into The FDA Gamble: Initiating Hims & Hers With A Buy (SeekingAlpha)
11:46AM	New Product Launches to Support HOLX Stock Amid Macro Issues (Zacks)
11:35AM	Hims & Hers Has Superstar Potential, But It Will Take A Lot To Get There (SeekingAlpha)
09:44AM	TMO Stock Set to Gain From the Launch of New Vulcan Automated Lab (Zacks)
Mar-19-25 11:54AM	Sale of Ozempic Knockoffs Is Supposed to End Soon. Telehealth Companies Arent Happy. (The Wall Street Journal) +7.59%
Mar-18-25 02:04PM	Why Hims & Hers Health (HIMS) Shares Are Trading Lower Today (StockStory) -9.22%
08:45AM	Is Viking Therapeutics the Next Blockbuster GLP-1 Stock? (MarketBeat)
05:30AM	Loading…
Mar-13-25 05:30AM	They Wanted a Quick Fix for Hair Loss. Instead, These Young Men Got Sick. (The Wall Street Journal) -7.04%
01:00AM	Defiance Launches RKLX and HIMZ: 2X Leveraged ETFs for Rocket Lab and Hims & Hers (GlobeNewswire)
Mar-11-25 05:30AM	Define Ventures Appoints Carolyn Magill as Venture Partner (PR Newswire)
Mar-10-25 11:02AM	Despite Challenges Novo Nordisk Plans to Crush GLP-1 Competitors (MarketBeat)
Mar-07-25 06:19PM	DoorDash, TKO Group Holdings, Williams-Sonoma and Expand Energy Set to Join S&P 500; Others to Join S&P 100, S&P MidCap 400 and S&P SmallCap 600 (PR Newswire)
02:52PM	Why Hims & Hers Health, Inc. (HIMS) Crashed on Thursday (Insider Monkey)
Mar-06-25 05:33PM	Walgreens stock rises amid $10 billion deal with Sycamore Partners to take the drugstore chain private (Yahoo Finance) -15.90%
05:33PM	Walgreens announces up to $27.3B deal with Sycamore Partners (Yahoo Finance)
05:33PM	Walgreens announces a $10 billion deal with Sycamore Partners to take the drugstore chain private (Yahoo Finance)
Mar-05-25 04:17PM	Hims Stock Claws Back After Novo Nordisk Undercuts It With A Cheaper Wegovy (Investor's Business Daily)
11:51AM	Hims & Hers Hammered After Novo Nordisk Undercuts It With A Cheaper Wegovy (Investor's Business Daily)
09:51AM	Novo Nordisk Slashes Wegovy Price, Undercutting Hims & Hers Health (Investor's Business Daily)
Feb-28-25 11:49AM	Behind Hims Stock's Roller-Coaster Ride As Weight-Loss Drugs Battle Heats Up (Investor's Business Daily) +9.07%
Feb-25-25 04:19PM	Why IBD 50's Top Seed, Hims & Hers, Just Crashed On Its Upbeat Earnings (Investor's Business Daily) -22.32% +5.09%
03:32PM	Stock Market Today: Dow Jones Improves; Tesla Skids Again While Techs Keep Tumbling (Live Coverage) (Investor's Business Daily)
11:52AM	Loading…
11:52AM	Hims & Hers tumbles 27% as investors fear uncertainty without compounded weight-loss drugs (Yahoo Finance)
11:21AM	Home Depot, Hims & Hers, bitcoin and crypto stocks: Market Minute (Yahoo Finance Video)
11:07AM	Stock Market Today: Dow Jones, S&P 500 Fall; Hims & Hers Tanks, Bitcoin Falls (Live Coverage) (Investor's Business Daily)
09:53AM	Hims & Hers stock collapses, may halt some weight-loss drug sales (Yahoo Finance Video)
Feb-24-25 06:21PM	Hims & Hers to 'treat multiple specialties,' not just weight loss (Yahoo Finance Video)
04:26PM	Hims & Hers stock tumbles despite beating Q4 revenue estimates (Yahoo Finance Video)
04:17PM	IBD 50's No. 2, Hims & Hers, Crashes 15% Despite Upbeat Earnings (Investor's Business Daily)
04:05PM	Hims & Hers Health, Inc. Reports Fourth Quarter and Full Year 2024 Financial Results (Business Wire)
12:57PM	What To Expect When IBD 50's No. 2, Hims & Hers, Reports Amid The Semaglutide Battle (Investor's Business Daily)
Feb-22-25 07:31PM	Why Hims & Hers Health, Inc. (HIMS) Crashed on Friday (Insider Monkey)
Feb-21-25 04:33PM	Hims Stock Crashes After FDA Resolves Weight-Loss Drugs Shortage (Investor's Business Daily) -25.79%
04:16PM	Hims & Hers shares dive on end of weight loss drug shortage (Yahoo Finance Video)
12:39PM	CrowdStrike, Hims & Hers, Rivian: Market Minute (Yahoo Finance Video)
09:00AM	Hims & Hers Acquires US-based Peptide Facility (Business Wire)
Feb-20-25 12:00PM	Apple unveils iPhone 16e, Arista reports Q4 beat: Morning Buzz (TipRanks)
Feb-19-25 05:23PM	'Health insurance companies are always going to need a PBM': CVS president Prem Shah (Yahoo Finance) +17.50%
04:12PM	Hims & Hers Health surges on acquisition for at-home testing (Yahoo Finance Video)
03:24PM	Short sellers lose $73 billion amid market rally to start 2025 (Yahoo Finance)
09:00AM	Hims & Hers Acquires At-Home Lab Testing Facility, Expanding Capabilities to Ultimately Include Affordable Whole Body Testing for Subscribers (Business Wire)
Feb-13-25 03:52PM	Senate confirms RFK Jr. as Trump's health secretary (Yahoo Finance Video) +27.71%
03:32PM	Hims & Hers stock sees another spike in trading days after Super Bowl ad (Yahoo Finance)
Feb-12-25 08:23AM	Hims & Hers Option Trade Offers $410 Return Or 17% Discount (Investor's Business Daily) +6.33%
Feb-10-25 04:27PM	Stock Market Today: Nvidia Helps Boost Dow Jones Higher; Meta Keeps Rally Alive (Live Coverage) (Investor's Business Daily) +5.22%
02:58PM	Stock Market Today: Nvidia A Big Gainer On Dow Jones; Uber Looks To Keep Rally Going (Live Coverage) (Investor's Business Daily)
01:33PM	Stock Market Today: Dow Jones Gets Help From Nvidia; Palantir Back Near A High (Live Coverage) (Investor's Business Daily)
12:20PM	Super Bowl: AI ads just 'fell flat' during the big game (Yahoo Finance Video)
10:34AM	Hims & Hers Super Bowl ad stirs up controversy with lawmakers (Yahoo Finance Video)
07:00AM	Hims Super Bowl Ad Spotlights Weight-Loss Drug Copycats as Clock Ticks on Their Business (The Wall Street Journal)
Feb-07-25 04:42PM	IBD 50 Stock Hims & Hers Faces Backlash Over Provocative Super Bowl Ad (Investor's Business Daily) +5.14%
06:00AM	Super Bowl Ads Will Be High on AI, Low on Politics (The Wall Street Journal)
Feb-04-25 09:00AM	Hims & Hers Launches Health Collective and Community Member Council (Business Wire) +7.50%
Feb-03-25 04:05PM	Hims & Hers to Announce Fourth Quarter and Full Year 2024 Financial Results on February 24, 2025 (Business Wire)
12:17PM	Hims & Hers Health Inc. (HIMS): Among The Stocks That Started The Year On A High (Insider Monkey)
Feb-02-25 04:37PM	Why Hims & Hers Health (HIMS) Is Among the Best Booming Stocks to Invest in Now? (Insider Monkey)
Feb-01-25 05:29PM	Why Hims & Hers Health (HIMS) Skyrocketed on Friday? (Insider Monkey)
Jan-28-25 06:00AM	Hims & Hers to Advertise Weight-Loss Shots at the Super Bowl (The Wall Street Journal)
Jan-26-25 02:00AM	Why Hims & Hers Health, Inc. (HIMS) Is Skyrocketing Now (Insider Monkey)
Dec-19-24 04:18PM	IBD 50's Hims & Hers Tumbles After FDA Pulls Lilly's Weight-Loss Drug From Shortage List (Investor's Business Daily) -7.67%
04:03PM	Eli Lily GLP-1 shortage ends, FDA says: Hims & Hers stock falls (Yahoo Finance Video)
03:57PM	FDA finalizes decision to end Lilly's GLP-1 shortage, analysts predict Novo will be next (Yahoo Finance)
Dec-17-24 10:48AM	Tesla, crypto miners, Hims & Hers Health: Trending Tickers (Yahoo Finance Video)
Dec-12-24 09:00AM	The Shape of America 2024: Hims and Hers Shares an In-Depth Look Into How Americans Feel About Weight (Business Wire)
09:00AM	The Shape of America 2024: Hims & Hers Shares an In-Depth Look Into How Americans Feel About Weight (Business Wire)
Dec-05-24 08:00AM	The Weight-Loss Battle That Could Rattle Eli Lilly's $100 Billion Market (Investor's Business Daily) -6.84%
Dec-03-24 12:58PM	Hims and Hers Named to Inc.s 2024 Best in Business List in Health Products Category (Business Wire)
12:58PM	Hims & Hers Named to Inc.s 2024 Best in Business List in Health Products Category (Business Wire)
Nov-25-24 04:14PM	Hims & Hers surges: Analysts say it's well-positioned under Trump (Yahoo Finance Video) +23.77%
Nov-21-24 12:00PM	Hims and Hers Expands Nutrition Support to Fuel Customers Weight Loss Journeys (Business Wire) +10.83%
12:00PM	Hims & Hers Expands Nutrition Support to Fuel Customers Weight Loss Journeys (Business Wire)
Nov-20-24 02:44PM	Guardant Health Stock Sees RS Rating Jump To 83 (Investor's Business Daily) -7.39%
Nov-18-24 06:00AM	Hims & Hers Appoints Tenured Pharmaceutical, Regulatory, and Quality Experts to Key Leadership Positions (Business Wire) +8.64%
Nov-17-24 04:53PM	Hims & Hers Health, Inc. (HIMS): A Bull Case Theory (Insider Monkey)
Nov-15-24 11:25AM	Netflix, Five Other Gems Soar Into Profit Zones In Hot November Rally (Investor's Business Daily) -7.34%
Nov-14-24 05:04PM	Hims & Hers Stock Drops After Amazon Says It Will Offer Hair-Loss Treatments (The Wall Street Journal) -24.46%
02:02PM	Stock Market Today: Chevron Breaks Out, But Biotechs Struggle As Eli Lilly Looks Like Short-Sale Play; Will American Airlines Break Out? (Live Coverage) (Investor's Business Daily)
Nov-13-24 09:48AM	Hims & Hers launches GLP-1 tracker in response to FDA's shortage decision (Yahoo Finance)
09:48AM	Hims & Hers launches GLP-1 shortage tracker in its battle with the FDA (Yahoo Finance)
09:15AM	Americans Continue to Struggle to Access Branded GLP-1s as Shortages Continue (Business Wire)
Nov-05-24 04:11PM	Hims Reports Strong Earnings, Novo Nordisk Copycat Drug Coming in 2025 (Investopedia) +13.47%
04:07PM	IBD 50's No. 2 Stock, Hims & Hers, Smashes Estimates On 'Robust' Obesity Trajectory (Investor's Business Daily)
12:29PM	Trump vs. Harris trades, Boeing, Hims & Hers: Top Stories (Yahoo Finance Video)
11:32AM	Stocks to Watch Tuesday: Palantir, Trump Media, Super Micro, Hims (The Wall Street Journal)
Nov-04-24 07:00PM	Hims & Hers Health jumps on earnings. CFO talks GLP-1 influences. (Yahoo Finance Video)
04:05PM	Hims & Hers Health, Inc. Reports Third Quarter 2024 Financial Results (Business Wire)
Oct-29-24 09:00AM	How Compounded Treatments Are Helping Hims & Hers Customers Meet Their Weight Loss Goals (Business Wire)
Oct-27-24 11:47AM	Why compounders and telehealth providers are undeterred by the potential end of the weight-loss drug shortage (Yahoo Finance)
Oct-22-24 09:00AM	Define Ventures Appoints Bruce Broussard as Venture Partner (PR Newswire)
Oct-21-24 01:43PM	Hims & Hers Health Tops Growth 50 List As FDA OKs Cheaper Weight-Loss Drug (Investor's Business Daily)
09:00AM	Hims & Hers names Dr. Jessica Shepherd as Chief Medical Officer of Hers (Business Wire)
Oct-19-24 03:20PM	FDA not planning to take action against GLP-1 compounders, Endpoints says (TipRanks)

Hims & Hers Health, Inc. operates a telehealth consultation platform. It connects consumers to healthcare professionals, enabling them to access medical care for mental health, sexual health, dermatology and primary care. The company was founded in 2017 and is headquartered in San Francisco, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Okupe Oluyemi	Chief Financial Officer	Mar 21 '25	Sale	32.41	23,118	749,176	129,248	Mar 24 04:35 PM
Oluyemi Okupe	Officer	Mar 21 '25	Proposed Sale	34.75	69,442	2,413,110		Mar 21 05:00 PM
Carroll Patrick Harrison	Chief Medical Officer	Mar 18 '25	Sale	34.31	23,287	798,977	209,661	Mar 18 06:35 PM
Dudum Andrew	Chief Executive Officer	Mar 17 '25	Option Exercise	2.43	125,335	304,564	226,447	Mar 18 06:35 PM
Dudum Andrew	Chief Executive Officer	Mar 17 '25	Sale	33.98	128,127	4,353,124	173,655	Mar 18 06:35 PM
Dudum Andrew	Chief Executive Officer	Mar 18 '25	Sale	33.85	78,760	2,666,199	94,895	Mar 18 06:35 PM
Dudum Andrew	Chief Executive Officer	Mar 17 '25	Sale	33.64	47,534	1,599,170	380,262	Mar 18 06:35 PM
Boughton Soleil	Chief Legal Officer	Mar 18 '25	Sale	34.31	3,236	111,027	173,521	Mar 18 06:35 PM
Becklund Irene	PAO	Mar 18 '25	Sale	34.31	8,277	283,984	10,210	Mar 18 06:34 PM
Dudum Andrew	Officer	Mar 18 '25	Proposed Sale	33.85	78,760	2,666,200		Mar 18 12:24 PM
Boughton Soleil	Officer	Mar 18 '25	Proposed Sale	34.31	3,236	111,027		Mar 18 10:56 AM
Carroll Patrick Harrison	Officer	Mar 18 '25	Proposed Sale	34.31	23,287	798,977		Mar 18 10:52 AM
Becklund Irene	Officer	Mar 18 '25	Proposed Sale	34.31	8,277	283,984		Mar 18 10:24 AM
Dudum Andrew	Officer	Mar 17 '25	Proposed Sale	33.89	175,661	5,952,296		Mar 17 03:26 PM
Becklund Irene	PAO	Mar 11 '25	Sale	34.77	2,203	76,598	2,203	Mar 13 04:31 PM
Becklund Irene	Officer	Mar 11 '25	Proposed Sale	34.77	2,203	76,598		Mar 11 10:03 AM
Becklund Irene	PAO	Mar 03 '25	Sale	45.14	2,913	131,493	4,406	Mar 05 04:42 PM
Pendarvis Christiane	Director	Mar 05 '25	Proposed Sale	40.00	12,500	500,000		Mar 05 11:40 AM
Becklund Irene	Officer	Mar 03 '25	Proposed Sale	45.14	2,913	131,493		Mar 03 11:59 AM
Boughton Soleil	Officer	Mar 03 '25	Proposed Sale	45.14	4,151	187,376		Mar 03 11:45 AM
Chi Michael	Chief Commercial Officer	Feb 24 '25	Option Exercise	5.01	17,303	86,688	210,904	Feb 25 04:38 PM
Chi Michael	Chief Commercial Officer	Feb 24 '25	Sale	48.14	17,303	832,966	193,601	Feb 25 04:38 PM
Chi Michael	Officer	Feb 24 '25	Proposed Sale	48.14	17,303	832,966		Feb 24 10:46 AM
Dudum Andrew	Chief Executive Officer	Feb 18 '25	Option Exercise	2.43	125,335	304,564	223,022	Feb 20 08:18 PM
Dudum Andrew	Chief Executive Officer	Feb 18 '25	Sale	58.27	128,127	7,466,121	97,687	Feb 20 08:18 PM
Dudum Andrew	Chief Executive Officer	Feb 18 '25	Sale	58.15	47,534	2,763,942	427,796	Feb 20 08:18 PM
Boughton Soleil	Chief Legal Officer	Feb 18 '25	Sale	60.69	4,152	251,985	157,345	Feb 20 08:17 PM
Chi Michael	Chief Commercial Officer	Feb 19 '25	Option Exercise	13.90	7,500	104,250	201,101	Feb 20 08:17 PM
Chi Michael	Chief Commercial Officer	Feb 19 '25	Sale	59.26	7,500	444,450	193,601	Feb 20 08:17 PM
Chi Michael	Officer	Feb 19 '25	Proposed Sale	59.26	7,500	444,450		Feb 19 10:16 AM
Boughton Soleil	Officer	Feb 18 '25	Proposed Sale	60.69	4,152	251,985		Feb 18 11:22 AM
Dudum Andrew	Officer	Feb 18 '25	Proposed Sale	58.24	175,661	10,230,058		Feb 18 11:10 AM
Baird Melissa	Chief Operating Officer	Feb 12 '25	Option Exercise	0.40	67,687	27,075	774,559	Feb 14 04:49 PM
Baird Melissa	Chief Operating Officer	Feb 12 '25	Sale	44.71	67,687	3,026,624	706,872	Feb 14 04:49 PM
Melissa Baird	Officer	Feb 12 '25	Proposed Sale	46.34	67,687	3,136,616		Feb 12 04:36 PM
Chi Michael	Chief Commercial Officer	Feb 10 '25	Option Exercise	6.82	7,259	49,506	200,860	Feb 11 04:16 PM
Chi Michael	Chief Commercial Officer	Feb 10 '25	Sale	43.28	7,259	314,170	193,601	Feb 11 04:16 PM
Okupe Oluyemi	Chief Financial Officer	Feb 10 '25	Option Exercise	5.01	6,437	32,249	119,370	Feb 11 04:16 PM
Okupe Oluyemi	Chief Financial Officer	Feb 10 '25	Sale	43.01	11,581	498,100	107,789	Feb 11 04:16 PM
Chi Michael	Officer	Feb 10 '25	Proposed Sale	43.28	7,259	314,170		Feb 10 12:09 PM
Okupe Oluyemi	Chief Financial Officer	Feb 04 '25	Option Exercise	5.01	6,437	32,249	124,514	Feb 05 04:31 PM
Okupe Oluyemi	Chief Financial Officer	Feb 04 '25	Sale	38.92	11,581	450,730	112,933	Feb 05 04:31 PM
Dudum Andrew	Chief Executive Officer	Jan 31 '25	Option Exercise	2.43	100,000	243,000	127,918	Feb 04 04:26 PM
Dudum Andrew	Chief Executive Officer	Jan 31 '25	Sale	35.22	100,000	3,522,300	27,918	Feb 04 04:26 PM
Boughton Soleil	Chief Legal Officer	Feb 03 '25	Sale	35.30	4,153	146,601	161,497	Feb 04 04:25 PM
Chi Michael	Chief Commercial Officer	Feb 03 '25	Option Exercise	11.53	2,054	23,683	195,655	Feb 04 04:25 PM
Chi Michael	Chief Commercial Officer	Feb 03 '25	Sale	35.30	2,054	72,506	193,601	Feb 04 04:25 PM
Boughton Soleil	Officer	Feb 03 '25	Proposed Sale	35.30	4,153	146,601		Feb 03 11:11 AM
Chi Michael	Officer	Feb 03 '25	Proposed Sale	35.30	2,054	72,506		Feb 03 11:11 AM
Dudum Andrew	Officer	Jan 31 '25	Proposed Sale	35.22	100,000	3,522,297		Jan 31 10:43 AM
Chi Michael	Chief Commercial Officer	Jan 24 '25	Option Exercise	5.01	17,304	86,693	210,905	Jan 24 05:20 PM
Chi Michael	Chief Commercial Officer	Jan 24 '25	Sale	31.00	17,304	536,424	193,601	Jan 24 05:20 PM
Dudum Andrew	Chief Executive Officer	Jan 23 '25	Option Exercise	2.43	27,098	65,848	55,016	Jan 24 05:20 PM
Dudum Andrew	Chief Executive Officer	Jan 23 '25	Sale	30.08	27,098	815,029	27,918	Jan 24 05:20 PM
Chi Michael	Officer	Jan 24 '25	Proposed Sale	31.00	17,304	536,424		Jan 24 09:53 AM
Boughton Soleil	Chief Legal Officer	Jan 21 '25	Option Exercise	5.01	50,000	250,500	219,803	Jan 23 04:32 PM
Boughton Soleil	Chief Legal Officer	Jan 21 '25	Sale	29.90	54,153	1,619,108	165,650	Jan 23 04:32 PM
Baird Melissa	Chief Operating Officer	Jan 21 '25	Option Exercise	0.40	67,687	27,075	774,559	Jan 23 04:32 PM
Baird Melissa	Chief Operating Officer	Jan 21 '25	Sale	29.35	67,687	1,986,731	706,872	Jan 23 04:32 PM
Chi Michael	Chief Commercial Officer	Jan 21 '25	Option Exercise	13.90	306	4,253	193,907	Jan 23 04:32 PM
Chi Michael	Chief Commercial Officer	Jan 21 '25	Sale	28.68	306	8,776	193,601	Jan 23 04:32 PM
Dudum Andrew	Chief Executive Officer	Jan 22 '25	Option Exercise	2.43	14,269	34,674	42,187	Jan 23 04:32 PM
Dudum Andrew	Chief Executive Officer	Jan 21 '25	Option Exercise	2.43	300	729	28,218	Jan 23 04:32 PM
Dudum Andrew	Chief Executive Officer	Jan 22 '25	Sale	30.08	14,269	429,184	27,918	Jan 23 04:32 PM
Dudum Andrew	Chief Executive Officer	Jan 21 '25	Sale	30.00	300	9,000	27,918	Jan 23 04:32 PM
Dudum Andrew	Officer	Jan 23 '25	Proposed Sale	30.08	27,098	815,030		Jan 23 12:55 PM
Dudum Andrew	Officer	Jan 22 '25	Proposed Sale	30.08	14,269	429,184		Jan 22 04:24 PM
Melissa Baird	Officer	Jan 21 '25	Proposed Sale	29.81	67,687	2,017,749		Jan 21 04:55 PM
Dudum Andrew	Officer	Jan 21 '25	Proposed Sale	30.00	300	9,000		Jan 21 04:54 PM
Boughton Soleil	Officer	Jan 21 '25	Proposed Sale	29.90	54,153	1,619,108		Jan 21 04:32 PM
Dudum Andrew	Chief Executive Officer	Jan 16 '25	Option Exercise	2.43	33,668	81,813	64,378	Jan 21 04:13 PM
Dudum Andrew	Chief Executive Officer	Jan 16 '25	Sale	27.01	47,534	1,283,884	475,330	Jan 21 04:13 PM
Dudum Andrew	Chief Executive Officer	Jan 16 '25	Sale	27.09	36,460	987,529	27,918	Jan 21 04:13 PM
Chi Michael	Officer	Jan 21 '25	Proposed Sale	28.68	306	8,776		Jan 21 10:16 AM
Dudum Andrew	Officer	Jan 16 '25	Proposed Sale	27.04	83,994	2,271,414		Jan 16 12:40 PM
Okupe Oluyemi	Chief Financial Officer	Jan 13 '25	Option Exercise	5.01	6,437	32,249	129,658	Jan 14 04:31 PM
Okupe Oluyemi	Chief Financial Officer	Jan 13 '25	Sale	24.44	11,581	283,083	118,077	Jan 14 04:31 PM
Chi Michael	Chief Commercial Officer	Jan 10 '25	Option Exercise	6.82	7,259	49,506	200,860	Jan 14 04:31 PM
Chi Michael	Chief Commercial Officer	Jan 10 '25	Sale	24.07	7,259	174,724	193,601	Jan 14 04:31 PM
Chi Michael	Officer	Jan 10 '25	Proposed Sale	24.07	7,259	174,724		Jan 10 10:39 AM
Boughton Soleil	Chief Legal Officer	Jan 06 '25	Option Exercise	3.85	254,023	979,134	438,735	Jan 07 04:48 PM
Boughton Soleil	Chief Legal Officer	Jan 06 '25	Sale	27.75	268,932	7,463,195	169,803	Jan 07 04:48 PM
Okupe Oluyemi	Chief Financial Officer	Jan 02 '25	Option Exercise	5.01	6,437	32,249	134,802	Jan 06 04:40 PM
Okupe Oluyemi	Chief Financial Officer	Jan 02 '25	Sale	24.68	11,581	285,784	123,221	Jan 06 04:40 PM
Chi Michael	Chief Commercial Officer	Jan 02 '25	Option Exercise	11.53	2,055	23,694	195,656	Jan 06 04:39 PM
Chi Michael	Chief Commercial Officer	Jan 02 '25	Sale	24.62	2,055	50,594	193,601	Jan 06 04:39 PM
Boughton Soleil	Officer	Jan 06 '25	Proposed Sale	27.75	268,932	7,463,195		Jan 06 01:05 PM
Chi Michael	Officer	Jan 02 '25	Proposed Sale	24.62	2,055	50,594		Jan 02 10:51 AM
Baird Melissa	Chief Operating Officer	Dec 27 '24	Option Exercise	4.56	31,518	143,669	706,872	Dec 30 04:22 PM
Okupe Oluyemi	Chief Financial Officer	Dec 26 '24	Sale	29.98	4,213	126,318	128,365	Dec 27 04:48 PM
Chi Michael	Chief Commercial Officer	Dec 24 '24	Option Exercise	5.01	17,303	86,688	210,904	Dec 27 04:47 PM
Chi Michael	Chief Commercial Officer	Dec 24 '24	Sale	27.97	17,303	483,965	193,601	Dec 27 04:47 PM
Chi Michael	Officer	Dec 24 '24	Proposed Sale	27.97	17,303	483,965		Dec 26 08:51 AM
Chi Michael	Chief Commercial Officer	Dec 19 '24	Option Exercise	13.90	7,500	104,250	201,101	Dec 23 04:40 PM
Chi Michael	Chief Commercial Officer	Dec 19 '24	Sale	26.00	7,500	195,000	193,601	Dec 23 04:40 PM
Okupe Oluyemi	Chief Financial Officer	Dec 20 '24	Sale	25.77	18,959	488,531	132,578	Dec 23 04:40 PM
Oluyemi Okupe	Officer	Dec 20 '24	Proposed Sale	26.20	69,496	1,820,795		Dec 20 04:34 PM
Chi Michael	Officer	Dec 19 '24	Proposed Sale	26.00	7,500	195,000		Dec 19 10:13 AM
Chi Michael	Chief Commercial Officer	Dec 17 '24	Sale	32.20	25,550	822,710	193,601	Dec 17 07:03 PM
Becklund Irene	PAO	Dec 16 '24	Option Exercise	9.41	472	4,442	17,803	Dec 17 07:02 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

Hims & Hers Health Inc

Upgrade your FINVIZ experience